Advertisement
Advertisement

EW

EW logo

Edwards Lifesciences Corp

78.71
USD
Sponsored
+0.61
+0.78%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

78.60

-0.11
-0.14%

EW Earnings Reports

Positive Surprise Ratio

EW beat 24 of 39 last estimates.

62%

Next Report

Next Week
Date of Next Report
Feb 10, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.59B
/
$0.63
Implied change from Q3 25 (Revenue/ EPS)
+2.55%
/
-5.97%
Implied change from Q4 24 (Revenue/ EPS)
+14.93%
/
+6.78%

Edwards Lifesciences Corp earnings per share and revenue

On Oct 30, 2025, EW reported earnings of 0.67 USD per share (EPS) for Q3 25, beating the estimate of 0.61 USD, resulting in a 9.62% surprise. Revenue reached 1.55 billion, compared to an expected 1.54 billion, with a 0.84% difference. The market reacted with a -1.23% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 31 analysts forecast an EPS of 0.63 USD, with revenue projected to reach 1.59 billion USD, implying an decrease of -5.97% EPS, and increase of 2.55% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
logo
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
logo
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
logo
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
logo
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
logo
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
logo
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
logo
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
FAQ
For Q3 2025, Edwards Lifesciences Corp reported EPS of $0.67, beating estimates by 9.62%, and revenue of $1.55B, 0.84% above expectations.
The stock price moved down -1.23%, changed from $83.48 before the earnings release to $82.45 the day after.
The next earning report is scheduled for Feb 10, 2026.
Based on 31 analysts, Edwards Lifesciences Corp is expected to report EPS of $0.63 and revenue of $1.59B for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement